TARO - Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24 revenue of $156.7M beats by $6.8M July, 27 2022 05:56 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical press release ( NYSE: TARO ): Q2 Non-GAAP EPS of $1.09 beats by $0.24 . Revenue of $156.7M (+6.5% Y/Y) beats by $6.8M . For further details see: Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M